NCT00783224

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)

Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 351 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

This study was conducted to see if mometasone nasal spray is efficaceous for the treatment of perennial allergic rhinitis. Patients will be randomized to active mometasone, placebo mometasone, active fluticasone, or placebo fluticasone.

Conditions

• Perennial Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Placebo for MF	Placebo to mometasone furoate nasal spray, indistinguishable from mometasone furoate nasal spray. Patients in this arm take 2 sprays per nostril once a day for 2 weeks
DRUG	Placebo for FP	Placebo to fluticasone nasal spray, indistinguishable from fluticasone propionate nasal spray. Patients in this arm take 2 sprays per nostril twice a day for 2 weeks
DRUG	Mometasone	Mometasone furoate nasal spray. Patients in this arm take 2 sprays per nostril once a day for 2 weeks
DRUG	Fluticasone	Fluticasone propionate nasal spray. Patients in this arm take 2 sprays per nostril twice a day for 2 weeks

Timeline

• Start date: 2005-09-01
• Primary completion: 2005-11-01
• Completion: 2005-12-01
• First posted: 2008-10-31
• Last updated: 2022-02-09
• Results posted: 2010-07-12